High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings. (2nd December 2022) - Singh, Charanpreet; Wadhera, Sarthak; Yanamandra, Uday; Karunakaran, Parathan; Jindal, Nishant; Kumar, Saloni Rani; Saini, Neha; Jandial, Aditya; Jain, Arihant; Das, Chandan; Prakash, Gaurav; Khadwal, Alka; et al.